You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Medtronic
Dow
Colorcon
Merck

Last Updated: February 16, 2020

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: CABOZANTINIB S-MALATE


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

CABOZANTINIB S-MALATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Exelixis COMETRIQ cabozantinib s-malate CAPSULE;ORAL 203756 NDA Exelixis, Inc. 42388-011-14 4 BLISTER PACK in 1 CARTON (42388-011-14) > 1 KIT in 1 BLISTER PACK
Exelixis COMETRIQ cabozantinib s-malate CAPSULE;ORAL 203756 NDA Exelixis, Inc. 42388-012-14 4 BLISTER PACK in 1 CARTON (42388-012-14) > 1 KIT in 1 BLISTER PACK
Exelixis COMETRIQ cabozantinib s-malate CAPSULE;ORAL 203756 NDA Exelixis, Inc. 42388-013-14 4 BLISTER PACK in 1 CARTON (42388-013-14) > 21 CAPSULE in 1 BLISTER PACK
Exelixis Inc CABOMETYX cabozantinib s-malate TABLET;ORAL 208692 NDA Exelixis, Inc. 42388-023-26 30 TABLET in 1 BOTTLE (42388-023-26)
Exelixis Inc CABOMETYX cabozantinib s-malate TABLET;ORAL 208692 NDA Exelixis, Inc. 42388-023-36 30 TABLET in 1 BOTTLE (42388-023-36)
Exelixis Inc CABOMETYX cabozantinib s-malate TABLET;ORAL 208692 NDA Exelixis, Inc. 42388-023-37 15 TABLET in 1 BOTTLE (42388-023-37)
Exelixis Inc CABOMETYX cabozantinib s-malate TABLET;ORAL 208692 NDA Exelixis, Inc. 42388-024-26 30 TABLET in 1 BOTTLE (42388-024-26)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Merck
McKinsey
Express Scripts
Moodys